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Although the concept that dendritic cells (DCs) recognize pathogens through the engagement of Toll-like receptors is
widely accepted, we recently suggested that immature DCs might sense kinin-releasing strains of Trypanosoma cruzi
through the triggering of G-protein-coupled bradykinin B2 receptors (B2R). Here we report that C57BL/6.B2R
 /  mice
infected intraperitoneally with T. cruzi display higher parasitemia and mortality rates as compared to B2R
þ/þ mice.
qRT-PCR revealed a 5-fold increase in T. cruzi DNA (14 d post-infection [p.i.]) in B2R
 / heart, while spleen parasitism was
negligible in both mice strains. Analysis of recall responses (14 d p.i.) showed high and comparable frequencies of IFN-c-
producing CD4
þ and CD8
þ T cells in the spleen of B2R
 /  and wild-type mice. However, production of IFN-c by effector
T cells isolated from B2R
 / heart was significantly reduced as compared with wild-type mice. As the infection continued,
wild-type mice presented IFN-c-producing (CD4
þCD44
þand CD8
þCD44
þ) T cells both in the spleen and heart while B2R
 / 
mice showed negligible frequencies of such activated T cells. Furthermore, the collapse of type-1 immune responses in
B2R
 / mice was linked to upregulated secretion of IL-17 and TNF-a by antigen-responsive CD4
þT cells. In vitro analysis
of tissue culture trypomastigote interaction with splenic CD11c
þ DCs indicated that DC maturation (IL-12, CD40, and
CD86) is controlled by the kinin/B2R pathway. Further, systemic injection of trypomastigotes induced IL-12 production
by CD11c
þ DCs isolated from B2R
þ/þ spleen, but not by DCs from B2R
 /  mice. Notably, adoptive transfer of B2R
þ/þ
CD11c
þDCs (intravenously) into B2R
 / mice rendered them resistant to acute challenge, rescued development of type-1
immunity, and repressed TH17 responses. Collectively, our results demonstrate that activation of B2R, a DC sensor of
endogenous maturation signals, is critically required for development of acquired resistance to T. cruzi infection.
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by Trypanosoma cruzi, are critical for the development of protective type-1 responses during acute infection. PloS Pathog 3(11): e185. doi:10.1371/journal.ppat.0030185
Introduction
Chagas disease, the chronic cardiomyopathy caused by
infection with the intracellular parasitic protozoan Trypanoso-
ma cruzi, remains a major health problem in Central and South
America [1]. Although acute Chagas disease may have a fatal
outcome, the blood parasitemia, tissue parasite burden (liver,
spleen,andheart),andtheinﬂammatorysequeltendtosubside
with the onset of adaptive immunity. After several years of
asymptomatic infection, approximately 30% of infected
patients develop a chronic and progressive form of cardiomy-
opathy [2]. While not excluding a secondary pathogenic role
for autoimmunity, studies in humans and animal models
support the concept that parasite persistence in myocardial
tissuesistheprimarycauseofchronicimmunopathology[3–6].
Cohort studies with chagasic patients have linked chronic
heartpathologytoTH1-typeresponses[7],butthisproposition
wasrecentlycalledintoquestionbyareportindicatingthatthe
frequency of IFN-c-producing effector/memory T cells is
inverselycorrelatedwiththeseverityofchronicChagasdisease
[8]. Animal model studies established that acquired resistance
depends on development of serum antibodies as well as on
IFN-c-producing CD4
þand CD8
þT cells [9–12]. Recent studies
indicated that CCR5 has a suceptible phenotype, attributed to
impaired recruitment of effector T cells to parasitized heart
tissues [13,14]. Although the dominant epitope speciﬁcities
recognized by cytotoxic CD8 T cells are encoded by highly
polymorphic genes [15], it is still unclear how T. cruzi escapes
from immune surveillance [16–18].
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mechanims linking innate to adaptive immunity in the mouse
model of T. cruzi infection. Early studies about innate
resistance mechanisms indicated that macrophages upregu-
late nitric oxide (NO)-dependent trypanocydal responses [19]
due to ligand-induced signaling of Toll-like 2 receptors
(TLR2) [20,21] or TLR4 [22]. More recently, Baﬁca et al.
reported that macrophages sense T. cruzi DNA via triggering
of intracellular TLR9 [23]. Interestingly, they showed that
acute infection is more severe in TLR2
 /  TLR9
 /  mice than
in TLR9
 /  mice or either TLR2
 / - [23] or TLR4-deﬁcient
mice [22], albeit not as much as in the overtly susceptible
MyD88
 /  mice [24]. While not formally excluding an additive
innate role for TLR4, these collective studies suggested that
cooperative activation of TLR2 and TR9 may account for the
bulk of protective IFN-c responses generated by MyD88-
dependent signaling pathways [23,24]. Of note, analysis of
macrophage activation by MyD88-independent pathways
revealed that TLR/TRIF coupling promotes NO-dependent
microbicidal responses through upregulation of type I
interferons [25,26]. In spite of evidence that mice deﬁcient
in IL-12 [27] are highly susceptible to T. cruzi infection, it is
still uncertain if induction of TH1-responses is strictly
dependent on dendritic cell (DC) maturation by TLRs/
MyD88-dependent pathways. Pertinently, it was reported that
spleen cells from MyD88
 /  mice display small yet signiﬁcant
production of IL-12 and IFN-c [24,28]. These observations
imply that IL-12-dependent Th1 responses may be also
controlled by MyD88-independent mechanisms, such as the
NKT/CD1d pathway [29], or by endogenously released
bradykinin (BK), an endogenous danger signal driving DC
maturation [30–32].
‘‘Kinins’’, a small group of mediators related to the
nonapeptide BK, activate immature DCs [30] as well as
several other cell types through the binding to distinct
subtypes of G-protein-coupled receptors: B2R (constitutive)
and B1R (inducible) [33–36]. The B2R agonists, BK or lysyl-BK
(LBK), are proteolytically excised from an internal segment of
their parental (glyco)proteins, high or low molecular weight
kininogens, by plasma or tissue kallikreins, respectively [33].
In the settings of infections, however, kinins can be generated
through the direct action of microbial cysteine proteases,
such as gingipain of Porphyromonas gingivalis [37] and cruzipain
(CZP), the major cysteine protease of T. cruzi [38–41]. Using a
subcutaneous model of T. cruzi infection, we recently
demonstrated that trypomastigotes release kinins in periph-
eral tissues through the activity of CZP [31]. Once liberated
from plasma borne–kininogens, the short-lived kinin pep-
tides activate CD11c
þDCs via B2R, inducing IL-12 production
and stimulating the migration of these antigen-presenting
cells (APCs) from the periphery to the draining lymph nodes,
where they initiate TH1-like responses against T. cruzi [31,32].
Here we report that B2R-deﬁcient mice infected intraper-
itoneally by T. cruzi display a typical susceptible phenotype.
Adoptive cell transfer experiments demonstrate that CD11c
þ
DCs activated by the endogenous kinin/B2R-signaling path-
way are critically required for the induction and/or main-
tenance of activated effector CD4
þ and CD8
þ T cells, while
limiting the development of potentially detrimental IL-17-
producing CD4
þ T cell (TH17) responses in mice acutely
infected with T. cruzi.
Results
Infection by the Intraperitoneal Route Discloses a
Susceptible Phenotype in B2R
 /  Mice
In order to test the hypothesis that kinins may contribute
to immune control of T. cruzi infection [30,31], we injected
intraperitoneally B2R
þ/þ C57BL/6 and B2R
 /  mice with tissue
culture trypomastigotes (TCT) of either Dm28c strain (1 3
10
6) or Brazil strain (1 3 10
4). The data shown in Figure 1
indicate that wild-type mice infected with Dm28c TCT
developed a low blood parasitemia and all the animals
survived (Figure 1A, higher panel). In contrast, B2R
 /  mice
infected with Dm28c showed a precocious blood parasitemia
(day 13 post-infection [p.i.]), which further increased (ap-
proximately 3-fold) as the infection continued (23 d p.i.).
Mortality rates indicated that B2R
 /  mice infected by Dm28c
TCT started to die earlier (day 16) than wild-type mice and
were all dead by day 27 (Figure 1A, lower panel). We then
studied the outcome of infection with the Brazil strain. The
results (Figure S1) show that wild-type mice displayed a
relatively low blood parasitemia and the mortality rate did
not exceed 20%. In contrast, the B2R
 /  mice infected by
Brazil strain developed increased blood parasitemia, and 80%
of these animals were dead by day 28 (Figure S1).
We then further characterized the outcome of intra-
peritoneal infection with the Dm28c strain, using a lower
inoculum (6310
5). Analysis by real-time PCR (qPCR) showed
that heart tissues of infected B2R
 /  mice (14 d p.i.) contained
approximately 5-fold higher content of parasite DNA as
compared to wild-type heart (Figure 1B). Surprisingly, we
found that the parasite tissue burden in the spleen was very
low both in B2R
þ/þ(0.30 6 0.09 fg/100 ng host DNA) and B2R
 / 
(0.46 6 0.21 fg/100 ng host DNA) mice (Figure 1B). Thus,
unlike the scenario observed in extra-lymphoid tissues,
PLoS Pathogens | www.plospathogens.org November 2007 | Volume 3 | Issue 11 | e185 1731
DCs Sense T. cruzi through Bradykinin Receptors
Author Summary
Antibodies and IFN-c-producing effector T cells are essential for
the immune control of infection by Trypanosoma cruzi, the
intracellular protozoa that causes human Chagas disease. Despite
the potency of anti-parasite immunity, the parasites are not
cleared from their intracellular niches. Instead, a low grade chronic
infection prevails, provoking severe immunopathology in the
myocardium. Although it is well established that innate sentinel
cells sense T. cruzi through receptors for microbial structures, such
as Toll-like receptors, it remained unclear whether endogenous
inflammatory signals also contribute to the development of
adaptive immunity. The present study was motivated by awareness
that T. cruzi trypomastigotes (extracellular infective forms) are
equipped with proteases that liberate the pro-inflammatory
bradykinin peptide from an internal segment of kininogens. Here
we demonstrate that splenic dendritic cells (DCs), the antigen-
presenting cells that coordinate the adaptive branch of immunity
in lymphoid tissues, are potently activated via G-protein-coupled
bradykinin B2 receptors (B2R). Analysis of the outcome of infection
in B2R-knockout mice revealed that the mutant mice developed a
typical susceptible phenotype, owing to impaired development of
IFN-c-producing effector T cells. Notably, the immune dysfunction
of B2R-knockout mice was corrected upon cell transfer of wild-type
DCs, thus linking development of protective T cells to DCs’ sensing
of endogenous danger signals (kinins) released by trypomastigotes.parasite outgrowth in the spleen is controlled by mechanisms
that do not critically depend on activation of the kinin/B2R
pathway, at least so at relatively early stages (14 d) of
infection.
Analysis of the Temporal Course of Type-1 Immune
Responses in the Spleen
Since the tissue parasitism in the spleen of wild-type and
B2R
 /  mice (14 d p.i.) was marginal, we checked whether
type-1 effector cells were generated in lymphoid tissues of
both mice strains. Recall assays indicated that splenocytes
from wild-type or B2R
 /  vigorously secreted IFN-c upon
stimulation with soluble T. cruzi antigen (Ag) (Figure 2A).
Controls showed that, in the absence of T. cruzi soluble Ag,
there was no signiﬁcant production of IFN-c by the
splenocytes (Figure 2A). We then scrutinized the ex vivo recall
responses of CD4
þ or CD8
þ T cells derived from either wild-
type or B2R
 / spleen (isolated from infected or naı ¨ve mice, as
controls) using wild-type CD11c
þ DCs (puriﬁed from normal
spleen) as APCs, to exclude the possibility that eventual
defects in Ag processing/presentation by B2R
 /  DCs could
interfere with our ‘‘read-outs’’. In keeping with the potent
type-1 response elicited by unfractionated wild-type and
B2R
 / splenocytes (14 d p.i.), ﬂuorescent activated cell sorting
(FACS) analysis showed presence of high and comparable
frequencies (Figure 2B, lower panel) of IFN-c-producing
CD4
þ and CD8
þ T cells in the spleens of wild-type and B2R
 / 
mice (Figure 2B). Controls performed with Ag-stimulated
CD4
þ or CD8
þ T cells isolated from naı ¨ve mice did not
generate signiﬁcant frequencies of IFN-c-producing cells.
Consistent with the similar FACS proﬁles, ELISA assays
showed that IFN-c was vigorously secreted by Ag-responsive
splenic CD4
þor CD8
þT cells, irrespective of the mouse strain
origin (Figure 2C).
We then checked if the presence of type-1 CD4
þ and CD8
þ
effector T cells was maintained in the spleen as the infection
continued. Recall assays performed 2 wk later (28 d p.i.)
indicated that IFN-c production by wild-type splenocytes
remainedvigorous,whilethetype-1response ofAg-stimulated
B2R
 /  splenocytes declined sharply (Figure 3A). We then
repeated this analysis using CD4
þ or CD8
þ T cells puriﬁed
from the spleens of infected wild-type mice or B2R
 /  mice,
using wild-type DCs as APCs. Consistent with the data
obtained with splenocytes, we found that Ag-stimulated T
lymphocytes (CD4
þor CD8
þ) isolated from B2R
 / spleen (28 d
p.i.) secreted signiﬁcantly lower levels of IFN-c as compared to
wild-type splenic T cells (unpublished data). We then
performed FACS analysis to further characterize the pheno-
typic changes that occurred in the spleen, as the acute
infection advanced (28 d p.i.). Our results (Figure 3B) showed
that Ag-stimulated T cells isolated from wild-type spleen
showed high frequencies of IFN-c-producing CD4
þ and CD8
þ
T lymphocytes. Moreover, a signiﬁcant fraction of activated
CD4
þ and CD8
þ T cells isolated from spleen of wild-type
infectedmicedisplayedtheCD44surfacemarker.Asexpected,
additionofAgtoCD4
þorCD8
þTcellculturesfromnaı ¨vemice
did not lead to IFN-c production (Figure 3B, lower panel). In
contrast, B2R
 /  spleen presented low frequencies of IFN-c-
producing CD4
þ or CD8
þ effectors (CD44
 ) (Figure 3B).
Although we have no direct evidence that the Ag-responsive
T cells detected ex vivo include functionally active effectors, it
isworthwhilementioningthatadoptivetransferofCD4
þ/CD8
þ
T cells (isolated from wild-type mice at 60 d p.i.) into B2R
 / 
mice rendered these recipient mice resistant to lethal
infection (0% mortality, n ¼ 5; three independent experi-
ments), as compared to non-manipulated B2R
 /  mice (100%
Figure 1. B2R
 /  Mice Are Susceptible to T. cruzi Infection by the
Intraperitoneal Route
(A) Temporal course of infection with the Dm28c T. cruzi strain in B2R
þ/þ
and B2R
 /  mice. Parasitemia and survival curves of mice groups
intraperitoneally infected with 1 3 10
6 TCT of the Dm28c strain of
T. cruzi. Parasitemia was evaluated with 5 ll of each infected mouse’s
blood in an optical microscope. Mortality was recorded daily. The data
are representative of two independent experiments (n ¼ 5 mice/group).
Statistics were done by ANOVA and pair-wise comparisons were done by
the Tukey test (a*, p , 0.05; b* p , 0.01).
(B) Quantification of T. cruzi Dm28c in heart and spleen from infected
animals as described above. qPCR was performed as described in
Materials and Methods in 100 ng of total DNA at 14 d p.i. Bars represent
an average of four to five animals per group 6 SD. p , 0.05 between
tissue parasitism in heart from wild-type and B2R
 / -infected animals as
determined by Student t Test.
doi:10.1371/journal.ppat.0030185.g001
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 /  mice that received CD4
þ/CD8
þ T cells
from normal wild-type mice (100% mortality).
Type-1 Responses by Intracardiac CD4
þ and CD8
þ
T Cells from B2R
 /  mice Are Compromised at
Early Stages of Infection
As mentioned earlier in this section, we found a 5-fold
increase of T. cruzi DNA in the heart of B2R-deﬁcient mice
at day 14 p.i., as compared to wild-type heart (Figure 1C). In
view of these ﬁndings, we set out to determine if cardiac
tissues of wild-type and B2R
 /  mice contained type-1
effector T cells. Recall assays (again using wild-type splenic
CD11c
þ DCs as APCs) showed that IFN-c production by
intracardiac B2R
 /  CD4
þ T cells was signiﬁcantly diminished
(over 50%) as compared to responses elicited by experi-
enced CD4
þ T lymphocytes isolated from wild-type heart at
14 d p.i. ( p , 0.01) (Figure 4). Similarly, the initial recall
response of intracardiac CD8
þ T cells isolated from B2R
 / 
mice was approximately 60% lower than that of wild-type
CD8
þ T cells (Figure 4).
We then checked if the type-1 cytokine response of intra-
cardiac T cells from B2R
 /  mice was further compromised as
the infection continued. The FACS proﬁles of wild-type-
infected mice (28 d p.i.) revealed high frequencies of IFN-c-
producing intracardiac CD4
þ and CD8
þ T cells (Figure 5). In
addition, we found that the CD44 marker characteristic of
activated T cells was present in a signiﬁcant proportion of
wild-type intracardiac CD4
þT cells, and (to lower extent) also
in the CD8
þT cell subset (Figure 5, upper and lower panels). In
contrast, B2R
 /  mice exhibited very low frequencies of CD4
þ
and CD8
þT cells in the intracardiac CD3
þT cell pool at day 28
p.i. (Figure 5). Following the same trend, IFN-c-producing
CD4
þ or CD8
þ effector T cells, and activated phenotypes
(CD44
þCD4
þ and CD44
þCD8
þ T cells) were virtually absent
from B2R
 /  heart. Collectively, these results suggest that
activation of the endogenous kinin/B2R signaling pathway in
T. cruzi–infected mice may have an impact on the control
mechanisms affecting the temporal and spatial activity of
type-1 effectors.
The Depressed TH1 Response of B2R
 /  Infected Mice
Is Inversely Correlated with Increased Production of
IL-17 and TNF-a
Considering that the type-1 responses of B2R
 /  mice were
depressed both in the heart (as early as 14 d p.i.) and spleen (28
d p.i.), we then asked if these effects were coupled to TH2
upregulation.OurresultsindicatedthatAg-stimulatedTCD4
þ
Tcells(isolatedfromB2R
 / heartorspleen)didnotupregulate
IL-4 production (unpublished data). Since IFN-c inhibits TH17
lineage development in vitro [42,43], we wondered if the
reduced TH1 responses observed in B2R
 /  mice were accom-
panied by rises of IL-17- and TNF-a-producing T cells. Recall
responses made at 28 d p.i. (Figure 6A) revealed that splenic
CD4
þ T lymphocytes from wild-type mice did not secrete
signiﬁcant levels of IL-17, while splenic B2R
 /  CD4
þ
T cells upregulated IL-17. The same trend was found when
we measured TNF-a levels secreted by experienced B2R
 / 
CD4
þ T cells (Figure 6B). Similar data were obtained when we
compared Ag-stimulated responses of intracardiac CD4
þ
T cells isolated from B2R
 / versus wild-type mice, as discussed
later in this section. Collectively, these data suggest that the
TH17/TH1 ratio was drastically increased as the acute infection
advanced in the highly susceptible B2R
 / mice.
TCTInduceIL-12ProductionbySplenicCD11c
þDCsviaB2R
Since type-1 responses were impaired in infected B2R
 / 
mice, we sought to determine if IL-12 responses were
preserved, or not, in these mutant mice. To this end, we
inoculated Dm28c TCT (1 3 10
6) intravenously in wild-type
and B2R
 /  mice, isolated splenic CD11c
þ DCs 18 h p.i., and
measured IL-12 production by FACS. The results (Figure 7A)
showed a marked increase in the frequency of IL-12-
producing CD11c
þ DCs (8%) in B2R
þ/þ in relation to non-
infected controls (no IL-12 staining). In contrast, splenic
CD11c
þ DCs isolated from infected B2R
 /  mice showed a low
frequency (2%) of IL-12-positive cells (Figure 7A). These
results were corroborated by ELISA determinations of IL-12
responses produced by DCs isolated from intravenously
infected mice (Figure 7B). Of note, we found that macro-
phages (CD11b
þ F4/80
þ) from infected wild-type and B2R
 / 
mice show enhanced production of IL-12 as compared to
naı ¨ve mice, suggesting that alternative mechanisms (i.e., B2R-
independent) may govern IL-12 production by splenic macro-
phages (unpublished data). Extending these in vivo studies to
BALB/c mice, these animals were pre-treated, or not, with the
B2R antagonist HOE-140 before intravenous injection of
TCT. The FACS proﬁles showed a sharp increase of IL-12-
positive CD11c
þDCs in BALB/c mice injected with either TCT
(Figure S2) or BK (positive control) (Figure S2). In contrast,
BALB/c mice pre-treated with HOE-140 showed a reduced
frequency of IL-12-positive CD11c
þ DCs (Figure S2). Collec-
tively, the data indicate that B2R drives IL-12 production by
splenic DCs, at least at very early stages of the infection.
We then carried out in vitro studies to verify if the parasites
could induce the maturation of CD11c
þ(splenic) DCs through
the activation of the kinin/B2R signaling pathway. IL-12
production and surface expression of co-stimulatory proteins
were used as read-out for DC maturation. FACS analyses
showed that CD11c
þ DCs (BALB/c) did not produce signiﬁ-
cant IL-12 levels in the absence of parasites (Figure 7C). In
contrast, IL-12 production was drastically increased upon
addition of exogenous BK (positive control) or TCT, whereas
HOE-140 cancelled both stimuli (Figure 7C). Notably, TCT
Figure 2. Splenic CD4
þ and CD8
þ T Cells from Infected B2R
þ/þ or B2R
 /  Mice Produce High Levels of IFN-c at the Early Stage (14 d p.i.) of Infection
Infections were performed by inoculation (intraperitoneally) of 6310
5 TCT (Dm28c). Spleens were removed from infected and non-infected B2R
þ/þand
B2R
 /  mice at 14 d p.i.
(A) Assessment of IFN-c production by splenocytes stimulated in vitro with T. cruzi Ag (25 lg/ml).
(B) Purified CD4
þ and CD8
þ T cells were co-cultured with CD11c
þ DCs loaded with T. cruzi Ag (25 lg/ml) for 18 h at 37 8C and were stained for CD4 or
CD8 and IFN-c as described in Materials and Methods. Dot plot profiles (n¼5 mice/group) are representative of results observed in four independent
experiments. Column graphs (lower panel) indicate the mean 6 SD of the frequency of IFN-c-producing CD4
þ or CD8
þ T cells (n ¼ 3).
(C)PurifiedCD4
þandCD8
þTcellswereco-culturedwithCD11c
þDCsloadedwith T.cruziAg(25lg/ml)for 72 hat37 8C, andsupernatants were harvested
and assayed for IFN-c levels by ELISA. Values are the mean 6 SD from one representative experiment with individual cells from five mice/group. Statistics
were done by ANOVA and pair-wise comparisons were done by the Tukey tests.
doi:10.1371/journal.ppat.0030185.g002
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þ and CD8
þ T Cells from T. cruzi–Infected B2R
þ/þ Mice (28 d p.i.) Produce High Levels of IFN-c
(A) Assessment of IFN-c production by splenocytes isolated from B2R
þ/þ and B2R
 /  mice infected at 28 d with Dm28c TCT. Cells were stimulated with
T. cruzi Ag (25 lg/ml) for 72 h at 37 8C. Culture supernatants were harvested and assayed for IFN-c.
(B) T cells were stimulated with T. cruzi Ag (25 lg/ml) for 18 h at 37 8C and were stained for CD4 or CD8, IFN-c, and CD44 marker as described in
Materials and Methods. Cells from B2R
þ/þ mice were gated on CD4
þIFN-c
þ or CD8
þIFN-c
þ lymphocytes and examined for expression of CD44. Dot plot
profiles(n¼5mice/group)arerepresentativeofresultsobservedinthreeindependentexperiments.Columngraphs(lowerpanel)indicatethemean6SD
ofthefrequencyofIFN-c-producingCD4
þCD44
þorCD8
þCD44
þTcells(n¼3).StatisticsweredonebyANOVAandpair-wisecomparisonsweredonebythe
Tukey test (*, p , 0.01).
doi:10.1371/journal.ppat.0030185.g003
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absence of lisinopril, a rather selective inhibitor angiotensin-
converting enzyme (ACEi) (Figure 7). Speciﬁcity controls
conﬁrmed that HOE-140 did not interfere at all with the
magnitude of IL-12 responses induced by lipopolysaccharide
(LPS) (Figure 7C). In agreement with the FACS data, ELISA
determinations of IL-12 levels in cultures supplemented with
HOE-140 conﬁrmed that TCT activate immature DCs
through B2R (Figure 7D). Controls in the absence of pathogen
indicated that lisinopril or HOE-140 as such did not induce
IL-12 production by DCs (Figure 7C). Additionally, DCs
cultivated with either TCT or BK (positive control) displayed
increased surface expression of CD40 and CD86 (Figure 7E).
Of note, HOE-140 cancelled the phenotypic changes induced
by TCT (Figure 7E, upper and lower panels), while responses
induced by BK were signiﬁcantly reduced by this B2R
antagonist (Figure 7E, lower panel).
Since TCT generate kinins via CZP while invading
endothelial cells, we next asked if parasite cysteine proteases
were required for DC activation. This question was addressed
by pre-incubating TCT with methylpiperazine-Phe-homo-
Phe-vinylsulfone-benzene (VSPh), an irreversible inhibitor of
CZP. After washing the VSPh-TCT, they were added to DC
cultures. Whether using FACS and ELISA, we found that
VSPh-TCT failed to drive signiﬁcant IL-12 production by DCs
(Figure 7C and 7D), adding weight to the concept that the
parasite relies on CZP to generate the innate kinin stimuli.
In order to verify whether the B2R
 / CD11c
þDCs were fully
capable of responding to TLR agonists, we compared the in
vitro response proﬁle induced by cytosine-phosphate-guanine
(CpG) and LPS. As shown in Figure 7F, IL-12 responses were of
the same magnitude as compared to wild-type C57BL/6 DCs.
Moreover, HOE-140 did not interfere with wild-type DC
responsiveness to CpG and LPS (Figure 7F). Notably, the
magnitude of B2R
 /  DC response to TCT was nearly 10% of
IL-12responsesobserved inwild-type CD11c
þDCs(Figure7F).
As expected, TCT or BK elicited vigorous IL-12 production in
CD11c
þ DCs from wild-type mice. In both cases, the IL-12
response was partially blocked by HOE-140 (Figure 7F). In
contrast, BK did not induce IL-12 in B2R
 /  DCs (Figure 7F).
Adoptive Transfer of CD11c
þ DCs from B2R
þ/þ into
Susceptible B2R
 /  Mice Restored Host Capability
to Control Infection through Induction of
Type-1 Effector T Cells
As mentioned earlier, we found that production of IFN-c
by Ag-experienced CD4
þand CD8
þT cells from B2R
 / spleen
and heart declined sharply as the infection continued (28 d
p.i.). In view of those ﬁndings, we asked whether the deﬁcient
type-1 responses of B2R
 /  mice were restored upon adoptive
transfer of wild-type DCs. To address this question, we
adoptively transferred (intravenously) immature B2R
þ/þ
CD11c
þ DCs (10
6 cells) into B2R
 /  mice before injection of
the parasites. As controls, recipient B2R
 /  mice received an
equivalent number of CD11c
þ DCs isolated from donor B2R
 /
  spleen. As expected, our controls showed that B2R
 /  mice
succumbed (100% mortality, n ¼ 5; three independent
experiments) at day 30. In contrast, 100% of the B2R
 / 
recipient mice reconstituted with B2R
þ/þ DCs survived the
acute challenge. Of note, the mice of the speciﬁcity control
group (B2R
 /  DCs ! B2R
 /  mice) succumbed (100%) to the
infection, thus ruling out the possibility that adaptive
immune function was restored due to non-speciﬁc activation
of these APCs during the DC isolation procedure. We then
ran another set of experiments to verify if the DC transfer
maneuver had restored (type-1) acquired immunity of B2R
 / 
recipient mice. Recall assays performed at day 28 p.i.
conﬁrmed that splenic or intracardiac (CD4
þ or CD8
þ)
T cells from control B2R
 /  mice secreted lower levels of
Figure 4. B2R
 / -Infected Mice Present Lower Frequencies of IFN-c-
Producing Intracardiac CD4
þand CD8
þT Cells at the Early Stage (14 d p.i.)
of Infection
Assessment of IFN-c production by heart-derived CD4
þ and CD8
þ T cells
isolated (14 d p.i.) from B2R
þ/þ and B2R
 /  mice. Cells were co-cultured
with CD11c
þ DCs loaded with T. cruzi Ag (25 lg/ml) for 72 h at 37 8C.
Culture supernatants were harvested and assayed for IFN-c by ELISA.
Data are representative of two independent experiments (n ¼ 5 mice/
group). Statistics were done by ANOVA and pair-wise comparisons were
done by the Tukey test (*, p , 0.05) .
doi:10.1371/journal.ppat.0030185.g004
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DCs Sense T. cruzi through Bradykinin ReceptorsIFN-c as compared to experienced CD4
þ or CD8
þ T cells
isolated from B2R
þ/þ spleen or heart (Figure 8A). Notably,
B2R
 /  mice that received adoptive transfer of B2R
þ/þ DCs
recovered the ability to generate IFN-c-producing CD4
þ and
CD8
þT cells (Figure 8A). Conversely, the DC transfer to B2R
 / 
mice repressed the secretion of IL-17 (Figure 8B) and TNF-a
(Figure 8C) by Ag-experienced (splenic or intracardiac) CD4
þ
T cells of the reconstituted B2R
 /  mice, therefore simulating
the phenotype of wild-type-infected mice.
Discussion
In the present work, we have demonstrated that the
immune dysfunction of B2R
 /  mice infected intraperito-
neally with T. cruzi is a consequence of defective sensing of
endogenously released kinins by immature CD11c
þ DCs. Our
analysis of the adaptive immune responses of infected B2R
 / 
appointed a role for the kinin signaling pathway in the
development of type-1 effector T cells. The critical impor-
tance of DCs as sensors of kinins was conﬁrmed by adoptive
cell transfers (wild type DC! B2R
 /  mice), which reversed
the susceptible phenotype of B2R
 /  mice while restoring the
development of type-1 effector T cells, both in the spleen and
cardiac tissues of recipient B2R
 /  mice.
The notion that the kinin-releasing trypomastigotes induce
DC maturation through B2R is supported by the following
experimental evidence. First, our in vitro studies showed that
TCT vigorously induced IL-12 responses in splenic DCs
originating from wild-type (C57BL/6) mice, while failing to
activate B2R
 /  DCs. Second, we demonstrated that HOE-140,
a speciﬁc antagonist of B2R,efﬁciently blocked DCmaturation
(IL-12 induction, upregulation of CD80, CD86, and CD40).
Figure 5. B2R
 / -Infected Mice Display Negligible Frequencies of Heart-Derived CD4
þand CD8
þ-Activated T Cells at Advanced Stages of Acute Infection
Heart-derived T cells were stimulated with T. cruziAg (25 lg/ml) for 18 h at 37 8C and were stained for CD4 or CD8, IFN-c, andCD44marker as described in
Materials and Methods. Cells from B2R
þ/þ mice were gated on CD4
þIFN-c
þ or CD8
þIFN-c
þ lymphocytes and examined for expression of CD44. Dot plot
profiles (n¼5 mice/group) are representative of results observed in two independent experiments. Column graphs (lower panel) indicate the mean 6 SD
of the frequency of IFN-c-producing CD4
þCD44
þor CD8
þCD44
þT cells (n¼2). Statistics were done by ANOVA and pair-wise comparisons were done by
the Tukey tests (*, p , 0.01).
doi:10.1371/journal.ppat.0030185.g005
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DCs Sense T. cruzi through Bradykinin ReceptorsFurthermore, the irreversible inhibitor of CZP (K11777)
mitigated the IL-12 stimulatory activity (B2R-driven) of TCT,
thus implicating the major cysteine protease of T. cruzi in the
kinin generation mechanism. Extending these observations to
the in vivo settings, we then analyzed IL-12 production by
splenic CD11c
þ DCs isolated 18 h after systemic inoculation
(intravenously) of Dm28c TCT. Experiments performed with
BALB/c mice showed that mice pre-treated with HOE-140
presented reduced frequencies of splenic CD11c
þIL-12
þDCs.
Adding weight to these results, we demonstrated that TCT
induced high frequencies of CD11c
þ IL-12
þ DCs in wild-type
(C57BL/6) spleen, while failing to evoke signiﬁcant IL-12
responses in DCs isolated from B2R
 /  spleen. Notably,
preliminary studies indicated that macrophages (CD11b
þF4/
80
þ) isolated from the spleen of these wild-type and B2R
 / 
mice develop comparable IL-12 responses. Given that type-1
immune responses in the spleen of B2R
 /  mice are well
preserved at day 14 p.i., it is possible that macrophages
activated by alternative routes provide the IL-12 signals that
drive adaptive immunity in this secondary lymphoid tissue.
Although we cannot claim that conventional DCs are the
primary or even unique in vivo targets of T. cruzi in the
spleen, the above mentioned results support the concept that
kinin-releasing pathogens may drive DC maturation in vivo
through the activation of G-protein-coupled B2 receptors
[32]. Since lymphoid tissues are irrigated by non-fenestrated
capillaries, we may predict that trypomastigotes invading the
splenic stroma are faced with an abundant supply of blood-
borne proteins, such as kininogens. Given biochemical
evidence that interactions of high molecular weight kinino-
gens with heparan sulfate proteoglycans potentiate the kinin-
releasing activity of CZP [40], it is plausible that the
extracellular trypomastigotes might promptly liberate these
paracrine signaling peptides while moving through extrac-
ellular matrices, hence driving DC maturation via B2R [31,32].
At ﬁrst sight, our ﬁnding that TCT induce DC maturation
via the endogenous kinin/B2R pathway appears to conﬂict
with the well-established concept that innate sentinel cells
sense pathogens via pattern recognition receptors (PRRs),
such as the members of the TLR family [28,44]. Indeed, early
studies of macrophage (IFN-c-primed) interaction with
T. cruzi (Y strain) suggested that TLR2 and TLR4 ligands
[20–22] are major drivers of innate responses in T. cruzi
infection. In a limited attempt to investigate the functional
relationship of B2R and TLRs, we examined the outcome of
TCT interaction in vitro with CD11c
þ DCs (splenic origin)
derived from either TLR2
 /  or TLR4
d/d mice. Our results
indicated that TCT induced vigorous IL-12 responses both in
TLR2
 /  DCs and TLR4
d/d DCs (unpublished data). Moreover,
we found that addition of HOE-140 to the TCT/DC culture
system blocked IL-12 responses by TLR2
 /  or TLR4
d/d DCs
(unpublished data). Admittedly, complementary studies with
DCs from double TLR2/TLR4 knockout mice and MyD88
 / 
mice are required to rule out the possibility that B2R-
responsive phenotypes of TLR2
 /  DCs and TLR4
d/d DCs
reﬂect compensatory responses, respectively induced by
TLR4 and TLR2 ligands of T. cruzi [20–22]. The intertwined
nature of the innate pathways controlling IL-12 production
by APCs is illustrated by the recent demonstration [23] that T.
cruzi DNA potently induces IL-12 production by mouse
macrophages through the activation of TLR9. Given the
evidence that DCs are parasitized by T. cruzi [45], it will be
interesting to determine if endogenous (BK/LBK) and
exogenous (T. cruzi DNA) danger signals may activate their
respective sensor receptors, B2R and TLR9, at distinct
temporal stages (i.e., early and late) of intracellular infection.
While examining the frequencies of type-1 effectors in
extra-lymphoid and lymphoid tissues of wild-type and B2R
 / -
infected mice, we became aware that B2R deﬁciency affected
the temporal and spatial distribution of IFN-c-producing
CD4
þ and CD8
þ T cells. Recall assays performed at day 14 p.i.
revealed weakened IFN-c production by intracardiac CD4
þ
and CD8
þ T cells isolated from B2R
 /  mice. However, we
found high and comparable frequencies of INF-c-producing
T cells in the spleen of the same B2R
 /  and wild-type mice.
Since the parasites are scarcely found in the spleens of wild-
type and B2R
 /  mice, we may infer that activation of the
kinin/B2R pathway is dispensable for early induction of type-1
effectors in the spleen. Adoptive cell transfer studies are
required to ﬁnd out if the induction of these early type-1
effector T cells is controlled by MyD88-coupled pathways
[24], such as those triggered by TLR2/TLR9 [23] and/or by IL-
1R/IL-18 R [44]. In addition, it is possible that IL-12 induction
by the NKT/CD1 pathway [29] may also contribute to early
development of type-1 effectors in lymphoid tissues.
Figure 6. The Depressed TH1 Response of B2R
 / -Infected Mice Is
Inversely Correlated with Increased Production of IL-17
Splenic CD4
þ T cells, isolated from infected B2R
þ/þ and B2R
 /  mice (28 d
p.i.). T cells were co-cultured with CD11c
þDCs pulsed with T. cruzi Ag (25
lg/ml) for 72 h at 37 8C. Culture supernatants were harvested and
assayed for IFN-c and IL-17 (A) and TNF-a (B) levels by ELISA. Values are
the mean 6 SD from one representative experiment with individual cells
from five mice/group. Statistics were done by ANOVA and pair-wise
comparisons were done by the Tukey test (a*, p , 0.05; b*, p , 0.01; *, p
, 0.05).
doi:10.1371/journal.ppat.0030185.g006
PLoS Pathogens | www.plospathogens.org November 2007 | Volume 3 | Issue 11 | e185 1738
DCs Sense T. cruzi through Bradykinin ReceptorsFigure 7. CD11c
þ DCs Sense TCT via the Kinin/B2R Activation Pathway
(A) IL-12 production by splenic CD11c
þ DCs of infected mice. B2R
þ/þ and B2R
 /  male mice were infected with 1310
6 TCT intravenously. Non-infected
animals served as control. CD11c
þ DCs were isolated from spleen of infected mice at 18 h p.i. and cultured in RPMI complete medium. FACS profiles
were done with CD11c-FITC and anti-IL12-PE (n ¼ 6 mice/group).
(B) ELISA determination of IL-12 production by CD11c
þ DCs from B2R
þ/þ and B2R
 /  mice non-infected and infected with 1 3 10
6 TCT intravenously.
Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p , 0.01).
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DCs Sense T. cruzi through Bradykinin ReceptorsIt is intriguing that intracardiac CD4
þ and CD8
þ T cells
from B2R
 /  mice (14 d p.i.) showed impaired production of
IFN-c, despite the fact that the spleen of these mice displayed
high frequencies of type-1 effectors. Coincidently, tissue
parasite burden is drastically increased in B2R
 /  heart, thus
showing an inverse correlation between these two parameters
at day 14 p.i. Although we cannot a priori assume that Ag
speciﬁcities of T cells recruited to the heart of wild-type and
B2R
 /  mice at 14 d p.i. are necessarily the same, independent
studies performed with the Brazil [46] and Y strain of T. cruzi
[47] converged in appointing cytotoxic CD8
þT cells as the key
effectors controlling intracellular parasite outgrowth in
cardiac tissues. So far, efforts to characterize the Ag speciﬁcity
of intracardiac CD8
þT cells in our infection model have been
hampered by the ﬁndings that Dm28c T. cruzi strain did not
present open reading frames for genes coding for ASP-2
antigens [48], which in other systems provide dominant
epitopes recognized by cytotoxic CD8
þT cells [46,47]. In spite
of these limitations, it is conceivable that immunoregulatory
dysfunctions were responsible for the weakened type-1
responses observed in peripheral T cells from B2R
 /  mice.
For example, it is possible that the migratory competence of
effector T cells generated in lymphoid tissues may depend on
DC activation via the kinin/B2R pathway. Pertinently, recent
analysis of the susceptible phenotype of CCR5
 /  mice
infected with T. cruzi implicated this chemokine receptor in
the recruitment of CD8
þ and CD4
þ effector T cells into
infected heart [13,14]. Given these precedent ﬁndings, it will
be worthwhile investigating if B2R and CCR5 signaling,
whether acting separately or in conjunction, might promote
the migration of effector T cells to peripheral sites of
infection, such as the heart.
As the infection advanced (14!28 d), wild-type mice
developed high frequencies of IFN-c-producing CD4
þ and
CD8
þ effector T cells, both in the spleen and heart.
Interestingly, a signiﬁcant proportion of these Ag-responsive
T cells displayed activated (CD44
þ) phenotypes. In contrast,
B2R
 /  mice showed negligible frequencies of activated type-1
effectors at day 28, both in spleen and heart. Of note, we
found that the intracardiac CD4
þ and CD8
þ T populations
recovered from the CD3
þ pool of B2R
 /  mice were signiﬁ-
cantly contracted (Figure 5). Considering that B2R
 /  mice
recovered the capacity to mount protective type-1 responses
upon adoptive transfer of wild-type DCs, it is possible that
maintenance of T cell homeostasis may depend, at least to
some degree, on DC responses elicited by endogenously
released kinins. Albeit speculative, this hypothesis is worth
exploring in light of independent reports showing that
aberrant T cell apoptosis is the primary cause of the
immunoregulatory abnormalities underlying host suscepti-
bility to acute infection by the Dm28c strain of T. cruzi [49].
Another intriguing phenotypic characteristic of infected
B2R
 / mice emerged when we monitored production of IL-17
and TNF-a in our recall assays. Unexpectedly, we found that
the weakened TH1 responses of B2R
 /  CD4
þ T cells (whether
isolated from the spleen/heart) at day 28 d p.i. was accom-
panied by upregulated production of IL-17 and TNF-a, two
pro-inﬂammatory cytokines associated with the effector
activity of TH17 cells. Recently characterized as a separate
lineage of pro-inﬂammatory T helper cells distinct from
conventional TH1 and TH2 cells [42,43], TH17 cells differ-
entiate from naı ¨ve precursors under the critical inﬂuence of
IL-6 and TGF-b1 [50]. It is also known that committed TH17
cells depend on the IL-23 survival signal to develop their
pro-inﬂammatoryfunctioninvivo[51].Notably,atearlystages
of infection (14 d p.i.), there was no signiﬁcant production of
IL-17 and TNF-a by spleen- or heart-derived T cells from
infected B2R
 / mice, whether detected by conventional recall
assays or polyclonal activation with anti-CD3 antibodies
(unpublished data). It is unclear why the TH1/TH17 balance
was inverted as the acute infection progressed in B2R
 /  mice.
Recently, IL-27 was identiﬁed as the cytokine that suppresses
TH17 differentiation driven by IL-6 and TGF-b via STAT-1,
independently of IFN-c [50]. Interestingly, T. cruzi–infected
WSX-1 mice (deﬁcient in the IL-27Ra) [52] develop severe
hepatic injury, correlating with overproduction of various
pro-inﬂammatory cytokines, such as IL-6, TNF-a, and IFN-c
[52]. Although TH17 responses were not evaluated in T. cruzi–
infected WSX-1 mice, these animals strongly upregulated TH2
cytokines [52]. However, we were unable to detect IL-4
production or IgG isotype switching in infected B2R
 /  mice,
indicating that these mice strains do not share the same
phenotype. Importantly, the recovery of type-1 responses in
DC recipient B2R
 /  mice was associated with reduced
production of IL-17 and TNF-a. Additional studies are
underway to determine if DCs activated by the kinin/B2R
pathway may inﬂuence TH1/TH17 lineage development in
T.cruziinfection viaIL-27, orthrough alternative mechanisms.
Collectively, our results have linked development of
acquired resistance to T. cruzi infection to DC functional
responses controlled by the kinin/B2R signaling pathway. Our
study provides a paradigm for investigations of the innate role
of endogenously released kinin ‘‘danger’’ signals in TH1/TH17
development in other infections and inﬂammatory diseases.
(C) Intracellular IL-12 produced by splenic CD11c
þDCs of BALB/c mice incubated in vitro with 10
6 TCT or VSPh-TCT, ratio DC/TCT (1:3), in the presence or
absence of 25 lM lisinopril (ACEi) for 18 h, and brefeldin A was added in the final 4 h. In same experiments, 10 nM BK was added to the medium, with or
without 0.1 lM HOE-140, 10 lM VSPh, or 10 ng/ml LPS, as indicated. FACS profiles were done with CD11c-FITC and anti-IL12-PE. Each bar represents the
% of DCs producing IL-12. Data represent the mean 6 SD from six independent experiments. Statistics were done by ANOVA and pair-wise
comparisons (represented by
a, b, c, d) were done by the Tukey test (*, p , 0.05).
(D) IL-12 levels in supernatants from splenic CD11c
þ DC cultures, as above. Statistics were done by ANOVA and pair-wise comparisons (represented
by
a, b, c, d) were done by the Tukey test (*, p ,0.01).
(E) Histograms for CD40 and CD86 expression in splenic CD11c
þDCs. Gray lines represent labeling by anti-CD40-FITC or anti-CD86-FITC, and bold black
lines represent labeling by isotype-matched control mAb (rat IgG2a-FITC). Dot plot profiles (n¼5 mice/group) are representative of results observed in
at least three independent experiments. Column graphs (lower panel) indicate the mean 6 SD of the frequency of CD11c
þCD40
þCD86
þDCs. Statistics
were done by ANOVA and pair-wise comparisons were done by the Tukey test (*, p , 0.05).
(F) ELISA determination of IL-12 production by splenic CD11c
þDCs from B2R
þ/þversus B2R
 / mice stimulated with TCT. Controls were done with BK (10
nM) and HOE-140 (0.1 lM) in the presence of 25 lM of ACEi (lisinopril). Controls were also performed with LPS (10 ng/ml) and CpG (100 ng/ml) in the
presence or absence of HOE-140 (0.1 lM). Data represent the mean 6 SD from three independent experiments done in triplicate each. Statistics were
done by ANOVA and pair-wise comparisons were done by the Tukey tests (*, p , 0.05).
doi:10.1371/journal.ppat.0030185.g007
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DCs Sense T. cruzi through Bradykinin ReceptorsMaterials and Methods
Mice and parasites. Experiments were done with mouse strains
BALB/c, C57BL/6 WT (B2R
þ/þ), and C57BL/6 B2R
 /  [53]. TCT (Dm28c
clone of T. cruzi) were harvested from the supernatants of infected
LLC-MK2 cultures maintained in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 2% FCS. Freshly released parasites were
washed 3X with excess PBS before being used in experiments.
Epimastigotes (EPI) of Dm28c clone of T. cruzi were cultivated in
standard liver infusion tryptose medium (LIT) containing 10% FCS
(GIBCO). Where indicated, TCT were pre-incubated for 20 min at RT
with 10 lM of VSPh.
InvitroactivationofCD11c
þDCisolatedfromnormalmousespleen.
Splenic DCs were isolated with anti-CD11c magnetic beads (Miltenyi
Biotec) and stimulated in vitro with TCT (3310
6/well) in DMEM/10%
fresh FCS for 18 h at 37 8C in the presence or absence of 25 lM
lisinopril (Lis; Sigma), an inhibitor of the angiotensin converting
enzyme (ACEi) and/or 0.1 lM HOE-140, as indicated. In some
experiments, DCs were treated with VSPh-TCT. Controls were done
with 10 nM BK, 10 ng/ml LPS, or 100 ng/ml CpG. For intracellular
staining of IL-12, 1310
6 DCs were washed and pre-incubated with 2%
of normal mouse serum (NMS) supplemented with anti-mouse CD16/
CD32FCcIII/IIreceptor(clone2.4G2) (1lg/10
6 cells)(BDBiosciences).
The washed cells were stained with anti-mouse CD11c-FITC (BD
Biosciences) in PBS/2% NMS. After washing (2X PBS), the cells were
ﬁxedin 2% paraformaldehyde,washed, andpermeabilized with0.05%
saponin (Sigma-Aldrich). Staining with PE-labeled anti-IL-12 p40/p70
(BD Biosciences) was performed in PBS/2% NMS/0.5% saponin.
Surface expression of co-stimulatory proteins was monitored by
incubating DCs with antibodies to CD40 or CD86 (BD Biosciences) in
thepresenceofPBS/2%NMS.Isotype-matchedcontrolwasperformed
withrat IgG-FITCorIgG1-PE(BD Biosciences). Samples wereanalyzed
by (FACSCalibur) (BD Biosciences), and data analyses were done with
CELLQuest software (BD Biosciences) or Win-MDI software (TSRI).
IsolationandcharacterizationofDCsfrommiceinfectedwithT.cruzi.
Mice were pre-treated or not with 10 mg/kg intraperitoneally of ACEi
(captopril) and/or 100 lg/kg subcutaneously of HOE-140, as
indicated, and 1 h later the mice were injected intravenously with
1 3 10
6 TCT. DCs were isolated from spleen at 18 h p.i. Brieﬂy,
pooled lymph node fragments were treated with collagenase D
(Sigma-Aldrich), and CD11c
þ DCs were positively selected using
magnetic beads covered with anti-mouse CD11c (Miltenyi Biotec;
90% pure). CD11c
þ DCs (10
6 cells/well) were incubated for 4 h in
RPMI complete medium with 10 lg/ml brefeldin A (Sigma-Aldrich)
and were stained for CD11c and IL-12 p40/p70 as described above.
Cytokine production by spleen- and heart-derived T cells isolated
from T. cruzi–infected mice. B2R
þ/þ and B2R
 /  mice were infected by
the intraperitoneal route with 6 3 10
5 TCT. After 28 d, splenocytes
were recovered and were stimulated with 25 lg/ml boiled soluble
T. cruzi antigen (EPI-Ag). Total CD3
þ T cells (T cell Enrichment
column; R&D Systems) were puriﬁed from either spleen or heart of
infected B2R
þ/þ or B2R
 /  mice (14 d and 28 d p.i.). CD4
þ and CD8
þ T
cells were also puriﬁed (14 d and 28 d p.i.) from spleen or heart of
infected mice with magnetic microbeads conjugated to anti-mouse
CD4
þand CD8
þ(Miltenyi Biotec) and isolated by passing over a MACs
LS
þ column held in a VarioMACS magnetic separator (Miltenyi
Biotec). Positively selected cells were 85%–95% pure, as determined
by ﬂow cytometry analysis. Recall assays were performed by co-
culturing 1 3 10
6 CD3
þ, CD4
þ, or CD8
þ T cells with 1 3 10
4 splenic
CD11c
þ DCs from B2R
þ/þ mice as APCs loaded with 25 lg/ml boiled
soluble T. cruzi antigen (EPI-Ag). Culture supernatants were collected
after 72 h and cytokines (IFN-c, IL-17, TNF-a) were quantiﬁed by
ELISA utilizing puriﬁed and biotinylated Abs (R&D Systems). Values
are presented as pg cytokine/ml (mean 6 SD). Statistical differences
between mean values were evaluated by ANOVA, and pair-wise
comparisons were done by the Tukey test.
Flow cytometry. B2R
þ/þ- and B2R
 / -infected mice were killed at the
time points indicated (14 d and 28 d p.i.) and single cell suspensions
werepreparedfromthespleenandheart.Redbloodcell–depletedcells
were stimulated with 25 lg/ml boiled soluble T. cruzi antigen (EPI-Ag)
and treated with anti-mouse CD16/CD32 FCc III/II receptor before
staining. Cells were then ﬁxed in 2% paraformaldehyde and stained
with FITC-labeled mouse antibody against CD4 or CD8, and PE-Cy-
labeled mouse antibody against CD44 (BD Biosciences). For intra-
cellular staining, stimulated cells were treated with brefeldin A (BD
Biosciences)andstainedwithPE-labeledanti-IFN(XMG1.2;eBioscien-
ces).SampleswereanalyzedbyFACSCalibur(BDBiosciences),anddata
analyses were done with CELLQuest software (BD Biosciences).
Quantiﬁcation of tissue parasite loads by qPCR. qPCR for parasite
quantiﬁcation was performed as described previously [54] with minor
modiﬁcations. Brieﬂy, DNA was isolated from spleen and heart tissues
of B2R
þ/þ and B2R
 /  mice infected by the intraperitoneal route with
6310
5 TCT, after digestion with proteinase K, followed by a phenol-
chloroform-isoamyl alcohol afﬁnity extraction. q-PCR using 100 ng of
total DNA was performed on an ABI PRISM 7900 sequence detection
system (Applied Biosystems) using SYBR Green PCR Master Mix
according to the manufacturer’s recommendations. Puriﬁed T. cruzi
DNA (American Type Culture Collection) was sequentially diluted for
curve generation in aqueous solution containing equivalent amounts
of DNA from uninfected mouse tissues. The equivalence of host DNA
between samples was normalized by levels of genomic beta-2
microglobulin (B2m) gene in the same samples. The following primers
were used for T. cruzi genomic DNA, TCZ, GCTCTTGCCCA
CACGGGTGC (forward), and CCAAGCAGCGGATAGTTCAGG
(reverse); and for genomic B2m, CTGAGCTCTGTTTTCGTCTG
(forward) and TATCAGTCTCAGTGGGGGTG (reverse).
Quantitative determination of IFNc levels by qPCR. B2R
þ/þ and
B2R
 /  mice were infected with 1 3 10
4 trypomastigotes of the Brazil
strain. Hearts were obtained at 15 d and 30 d p.i. RNA from the tissues
was isolated using the Trizol LS reagent following the manufacturer’s
protocol. Brieﬂy, 5 ng of RNA was reverse-transcribed in a ﬁnal
volume of 20 ll using Superscipt II transcriptase (Invitrogen). The
reverse transcription mixture consisted of 1 mM dNTPs (Pharmacia
Biotech), 20 mM dithiothreitol, 50 mM Tris HCl (pH 8.3), 75 mM KCl,
3 mM MgCl2, 2 ng hexamer (Pharmacia Biotech), and 200 U of
superscript RT RNase H- reverse transcriptase (Invitrogen). The
reaction was incubated for 50 min at 42 8C. The qPCR primers for
IFN-c were 59 forward GCGGCCTAGCTCTGAGACAA and 59 reverse
GACTGTGCCGTGGCAGTAAC, which ampliﬁed the 97-bp IFN-c
gene fragment. qPCR was carried out using magnesium chloride
(2 mM), primers, and the PCR Sybr Green Master Mix (Roche Applied
Science) in a ﬁnal volume of 20 ll. The reaction conditions for qPCR
used for quantiﬁcation of IFN-c have been previously described [55].
A standard curve for the quantiﬁcation of IFN-c was developed in the
range of 0.5 pg pg using the primers at same conditions. The result
was normalized using GAPDH mRNA for each sample. The primer
sequence and the conditions used for the real-time PCR quantiﬁca-
tion were the same as previously published [55].
Supporting Information
Figure S1. B2R
 /  Mice Are Also Susceptible to Brazil T. cruzi Strain
Infection by the Intraperitoneal Route
TemporalcourseofinfectionwiththeBrazilT.cruzistraininB2R
þ/þand
B2R
 /  mice. Parasitemia and survival curves of mice groups intra-
peritoneally infected with 1310
4 TCT of the Brazil strain of T. cruzi.
Parasitemia were evaluated with 5 ll of each infected mouse’s blood in
an optical microscope. Mortality was recorded daily. The data are
representative of two independent experiments (n¼10 mice/group).
Found at doi:10.1371/journal.ppat.0030185.sg001 (949 KB TIF).
Figure S2. Immature DCs Sense TCT via the Kinin/B2R Activation
Pathway
(A) IL-12 production by splenic CD11c
þDCs of infected mice. BALB/c
male mice were pre-treated or not with HOE-140 (100 lg/kg) for 1 h
prior to injection of 1 3 10
6 TCT intravenously. Non-infected ACEi-
treated animals served as control. CD11c
þ DCs were isolated from
spleen of infected BALB/c at 18 h p.i. and cultured in RPMI complete
medium. FACS proﬁles were done with CD11c-FITC and anti-IL12-
Figure 8. Adoptive Transfer of B2R
þ/þ CD11c
þ DCs into Susceptible B2R
 /  Mice Restores Type-1 Immunity
Assessment of cytokine production by splenic and heart-derived CD4
þand CD8
þT cells isolated (28 d p.i.) from B2R
þ/þ,B 2R
 / , and B2R
 / recipient mice.
The transfer of CD11c
þDCs (spleen B2R
þ/þ) into B2R
 / mice was carried out by the intravenous route. Purified T cells were co-cultured with CD11c
þDCs
loaded with T. cruzi Ag (25 lg/ml) for 72 h at 37 8C. Culture supernatants were harvested and assayed for IFN-c (A), IL-17 (B), and TNF-a (C) levels by
ELISA. Values are the mean 6 SD from one representative experiment with individual cells from five mice/group. Statistics were done by ANOVA and
pair-wise comparisons were done by the Tukey test (*, p , 0.05).
doi:10.1371/journal.ppat.0030185.g008
PLoS Pathogens | www.plospathogens.org November 2007 | Volume 3 | Issue 11 | e185 1742
DCs Sense T. cruzi through Bradykinin ReceptorsPE. Each bar represents the % of DCs producing IL-12 beyond
threshold levels. Data represent the mean 6 SD from two
independent experiments (n ¼ 6 mice/group). Statistics were done
by ANOVA and pair-wise comparisons (represented by
a, b, c, d) were
done by the Tukey test (*, p , 0.05).
Found at doi:10.1371/journal.ppat.0030185.sg002 (870 KB TIF).
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